University of Cambridge logo

OncoTherics signs collaboration agreement with University of Cambridge

Author: Stefan Ogrodzinski

OncoTherics has signed a collaboration agreement with the University of Cambridge to progress a series of novel preclinical investigations using OCT1002 in Pancreatic Tumour models.

The investigations will augment OncoTherics formal preclinical studies, providing useful additional information about OCT1002 in Pancreatic Cancer.